These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34107442)

  • 1. A glutathione-responsive polyphenol - Constructed nanodevice for double roles in apoptosis and ferroptosis.
    Chen H; Yan Z; Wu S; Li F
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111902. PubMed ID: 34107442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
    Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
    Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineering a pH/Glutathione-Responsive Tea Polyphenol Nanodevice as an Apoptosis/Ferroptosis-Inducing Agent.
    Mu M; Wang Y; Zhao S; Li X; Fan R; Mei L; Wu M; Zou B; Zhao N; Han B; Guo G
    ACS Appl Bio Mater; 2020 Jul; 3(7):4128-4138. PubMed ID: 35025415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.
    Xie X; Li Z; Tang H; Zhang Y; Huang Y; Zhang F; You Y; Xu L; Wu C; Yao Z; Peng X; Zhang Q; Li B
    Acta Biomater; 2024 Jul; 183():292-305. PubMed ID: 38838903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
    Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
    Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T
    Zhu L; Wang J; Tang X; Zhang C; Wang P; Wu L; Gao W; Ding W; Zhang G; Tao X
    ACS Appl Mater Interfaces; 2022 Jan; 14(3):3621-3632. PubMed ID: 35005898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.
    Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S
    Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin-Coated Metal-Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death.
    Xu Y; Guo Y; Zhang C; Zhan M; Jia L; Song S; Jiang C; Shen M; Shi X
    ACS Nano; 2022 Jan; 16(1):984-996. PubMed ID: 35023715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
    Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
    Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
    Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
    J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance.
    Yang C; Chen Z; Wei M; Hu S; Cai M; Wang N; Guan Y; Li F; Ding Q; Ling D
    J Control Release; 2023 May; 357():20-30. PubMed ID: 36940774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics.
    Wang S; Li F; Qiao R; Hu X; Liao H; Chen L; Wu J; Wu H; Zhao M; Liu J; Chen R; Ma X; Kim D; Sun J; Davis TP; Chen C; Tian J; Hyeon T; Ling D
    ACS Nano; 2018 Dec; 12(12):12380-12392. PubMed ID: 30495919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy.
    Yang Y; Zuo S; Li L; Kuang X; Li J; Sun B; Wang S; He Z; Sun J
    Asian J Pharm Sci; 2021 Nov; 16(6):784-793. PubMed ID: 35027953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
    Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
    Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
    Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
    Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of ferroptosis with a liposomal nanoreactor cooperates with low-toxicity doxorubicin apoptosis for enhanced tumor chemotherapy.
    Ji P; Wang X; Yin J; Yao Y; Du W
    Biomater Sci; 2022 Mar; 10(6):1544-1553. PubMed ID: 35171184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia.
    Wu T; Liang X; Liu X; Li Y; Wang Y; Kong L; Tang M
    Part Fibre Toxicol; 2020 Jul; 17(1):30. PubMed ID: 32652997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanolongan with Multiple On-Demand Conversions for Ferroptosis-Apoptosis Combined Anticancer Therapy.
    Bao W; Liu X; Lv Y; Lu GH; Li F; Zhang F; Liu B; Li D; Wei W; Li Y
    ACS Nano; 2019 Jan; 13(1):260-273. PubMed ID: 30616348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.